China Universal Asset Management Co., Ltd.
Position in CADL — Candel Therapeutics, Inc.
CIK 1906594
SHANGHAI, F4
Position in CADL
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$63,690
+$13,146 QoQ
Shares Held
12,998
+45.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026China Universal Asset Management Co., Ltd. holds $172,298,843 across 225 Biotechnology names. CADL ranks #186 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
43,902 | $19,603,999 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
21,361 | $16,504,363 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
27,266 | $9,021,501 | |
| 4 | INSM |
INSMED Inc
|
47,015 | $7,687,892 | |
| 5 | RPRX |
Royalty Pharma plc
|
130,447 | $6,257,542 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
77,315 | $5,805,583 | |
| 7 | ARGX |
Argenx SE
|
5,035 | $3,676,808 | |
| 8 | MRNA |
Moderna, Inc.
|
70,085 | $3,560,318 |
All Filings in CADL
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,690 | 12,998 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $50,544 | 8,946 | Shares | Sole | 2026-01-29 | |
| 2022-09-30 | $850 | 271 | Shares | Sole | 2022-10-21 | |
| No filing history on record for this holder in this stock. | ||||||